RU2011112243A - METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS - Google Patents
METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS Download PDFInfo
- Publication number
- RU2011112243A RU2011112243A RU2011112243/05A RU2011112243A RU2011112243A RU 2011112243 A RU2011112243 A RU 2011112243A RU 2011112243/05 A RU2011112243/05 A RU 2011112243/05A RU 2011112243 A RU2011112243 A RU 2011112243A RU 2011112243 A RU2011112243 A RU 2011112243A
- Authority
- RU
- Russia
- Prior art keywords
- prevention
- experimental animals
- subcutaneously
- systemic amyloidosis
- protein preparation
- Prior art date
Links
- 206010035226 Plasma cell myeloma Diseases 0.000 title claims abstract 3
- 238000010171 animal model Methods 0.000 title claims abstract 3
- 238000000034 method Methods 0.000 title claims abstract 3
- 230000002580 nephropathic effect Effects 0.000 title claims abstract 3
- 230000002265 prevention Effects 0.000 title claims abstract 3
- 208000022256 primary systemic amyloidosis Diseases 0.000 title claims abstract 3
- 102000004169 proteins and genes Human genes 0.000 claims abstract 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract 4
- 241000699673 Mesocricetus auratus Species 0.000 claims abstract 2
- 239000002671 adjuvant Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims abstract 2
- 239000007924 injection Substances 0.000 claims abstract 2
- 238000002347 injection Methods 0.000 claims abstract 2
- RVJVDCVIJCBUTH-UHFFFAOYSA-M sodium;5-amino-2h-phthalazin-3-ide-1,4-dione Chemical compound [Na+].O=C1N[N-]C(=O)C2=C1C(N)=CC=C2 RVJVDCVIJCBUTH-UHFFFAOYSA-M 0.000 claims abstract 2
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ профилактики системного амилоидоза и его нефропатической формы у экспериментальных животных, включающий введение сирийским хомякам белкового препарата подкожно и амилоидопротекторного препарата, отличающийся тем, что в качестве белкового препарата вводят нативную человеческую плазму смешанную с адъювантом фрейнда в равных пропорциях, инъекции осуществляют в симметричные подмышечные и паховые области и внутрибрюшинно из расчета 0,1 мл в каждую точку, однократно, а в качестве амилоидопротектора используют галавит, вводимый им одновременно через день подкожно в дозе 0,28 мг/кг в течение 60 дней. A method for the prevention of systemic amyloidosis and its nephropathic form in experimental animals, comprising administering to the Syrian hamsters a protein preparation subcutaneously and an amyloidoprotective drug, characterized in that native human plasma mixed with freund's adjuvant in equal proportions is administered as a protein preparation, injections are carried out in symmetrical axillary and inguinal area and intraperitoneally at the rate of 0.1 ml at each point, once, and as an amyloidoprotector use galavit, introduced by him dnovremenno subcutaneously every other day at a dose of 0.28 mg / kg for 60 days.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011112243/14A RU2473133C2 (en) | 2011-03-30 | 2011-03-30 | Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2011112243/14A RU2473133C2 (en) | 2011-03-30 | 2011-03-30 | Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2011112243A true RU2011112243A (en) | 2012-10-10 |
| RU2473133C2 RU2473133C2 (en) | 2013-01-20 |
Family
ID=47079079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011112243/14A RU2473133C2 (en) | 2011-03-30 | 2011-03-30 | Method for prevention of systemic amyloidosis and its nephropathic form in experimental animals |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2473133C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2657844C1 (en) * | 2017-01-09 | 2018-06-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Северо-Осетинская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method of treatment an experimental amyloid cardiopathy in rats |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI239847B (en) * | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
| RU2270672C1 (en) * | 2004-09-15 | 2006-02-27 | Северо-Осетинская государственная медицинская академия | Method for prophylaxis and treatment of systemic amyloidosis and nephropathic form thereof in experimental animals |
| WO2007125385A2 (en) * | 2005-12-22 | 2007-11-08 | Neurochem (International) Limited | Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
| RU2312663C1 (en) * | 2006-02-21 | 2007-12-20 | Закрытое акционерное общество "Центр современной медицины "Медикор" | Method for treatment of acute destructive pancreatitis |
| RU2383342C1 (en) * | 2008-07-16 | 2010-03-10 | Наталья Эдуардовна Романцева | Method of treating pulmonary tuberculosis in hiv-infection patients |
| RU2381797C1 (en) * | 2008-11-05 | 2010-02-20 | Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию | Method for prevention of systemic amyloidosis and its nephropatic form in experimental animals |
-
2011
- 2011-03-30 RU RU2011112243/14A patent/RU2473133C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2473133C2 (en) | 2013-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ630790A (en) | Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes | |
| RU2014150942A (en) | TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE | |
| EA201490254A1 (en) | COMBINED TREATMENT OF HEPATITIS C | |
| EA201791727A1 (en) | 7-BENZYL-4- (2-METHYLBENZIL) -2,4,6,7,8,9-HEXAHYDROIMIDAZO [1,2-A] PYRIDO [3,4-E] PYRIMIDIN-5 (1H) -OH, ITS ANALOGUES AND SALTS AND METHODS OF THEIR APPLICATION IN THERAPY | |
| EA201591715A1 (en) | COMBINED THERAPY WITH THE USE OF 7-BENZYL-10- (2-METHYLBENZYL) -2,6,7,8,9,10-HEXAHYDROIMIDAZO [1,2-a] PYRIDO [4,3-d] PYRIMIDIN-5 (3H) -SHE IS | |
| JP2015518818A5 (en) | ||
| AR082150A1 (en) | N-ETIL-N-Phenyl-1,2-DIHIDRO-4-HYDROXI-5-CHLORINE-1-METHYL-2-OXOQUINOLIN-3-CARBOXAMIDE DEUTERADA, SALTS AND USES OF THE SAME, TREATMENT METHOD, COMPOUND BLEND, COMPOSITION PHARMACEUTICS, PREPARATION PROCESS, ENRICHED COMPOUND WITH DEUTERIO | |
| RU2013123646A (en) | COMBINED COMPOSITION | |
| RU2015116264A (en) | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN PATIENTS WITH DIABETES | |
| FI3383385T4 (en) | Melflufen dosage regimens for cancer | |
| RU2014124171A (en) | MEDICINE FOR THERAPEUTIC TREATMENT AND / OR IMPROVEMENT OF SEPSIS | |
| EA201690057A1 (en) | OSTEOPONTIN MILK MAMMALS TO IMPROVE IMMUNOLOGICAL REACTIVITY | |
| EA201591233A1 (en) | COMPOSITION OF INJECTION DEPOSIT, INCLUDING OPTICALLY ACTIVE TOLVAPTAN, AND A METHOD FOR ITS OBTAINING | |
| RU2019109154A (en) | PHARMACEUTICAL COMPOSITION FOR THERAPY OF GROWTH HORMONE DEFICIENCY, CONTAINING THE FUEL PROTEIN hGH | |
| RU2015112121A (en) | MI-RNA AND THEIR APPLICATION IN METHODS AND COMPOSITIONS FOR TREATMENT AND / OR PREVENTION OF EYE CONDITIONS | |
| EA201691055A1 (en) | PREPARATIONS AND METHODS OF TREATMENT OF GD2-POSITIVE CANCER | |
| AR093908A1 (en) | FUSION OF HUMAN AND ALBUMINE GROWTH HORMONE, FORMULATION AND USES OF THE SAME | |
| EA201591653A1 (en) | COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL | |
| MY193963A (en) | Composition for treating joint diseases and kit containing same | |
| EA201791895A1 (en) | DOSES AND METHODS OF ADMINISTRATION TELAVANCIN | |
| RU2011112243A (en) | METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | |
| RU2018144248A (en) | Dosing regimens for vortioxetine for rapid onset of antidepressant effect | |
| RU2010153722A (en) | METHOD FOR INCREASING EFFECTIVENESS OF TREATMENT OF HYPOFUNCTIONS OF OVARIES IN COWS | |
| EA201491841A1 (en) | COMPOSITION OF ESMOLOL FOR PARENTERAL INTRODUCTION | |
| RU2011111891A (en) | METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130331 |